Bahtigul Azimova

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

Tashkent Pharmaceutical Institute(Current)

University of Chinese Academy of Sciences

Chengdu Institute of Biology

Bahtigul Azimova is an author at Tashkent Pharmaceutical Institute specializing in cell signaling, anti-inflammatory activity, and phosphodiesterase-4 inhibitors.

ORCID

Publications per year

2018–2024

Publications

Inhibition of TPL2 by interferon-α suppresses bladder cancer through activation of PDE4D

Zhe Qiang, Zongyuan Zhou, Ting Peng et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 23 citations · Full text

Medicine, Oncology, Pharmacology +14

Hypoglycemic and Anti-Inflammatory Effects of Triterpene Glycoside Fractions from Aeculus hippocastanum Seeds

Avez Sharipov, Khurshid Tursunov, Sunnatullo Fazliev et al. · Molecules · 2021 · 18 citations · Full text

Life Sciences, Botany, Medicinal Chemistry +16

Luteolin and its analog luteolin-7-methylether from Leonurus japonicus Houtt suppress aromatase-mediated estrogen biosynthesis to alleviate polycystic ovary syndrome by the inhibition of tumor progression locus 2

Xiaoke Shi, Ting Peng, Bahtigul Azimova et al. · Journal of Ethnopharmacology · 2024 · 15 citations

Life Sciences, Biochemistry, Endocrinology +14

1–3 of 3